Kimberly-Clark reported Q4 2024 results with net sales of $4.9 billion, a decrease of 0.8%, but organic sales grew by 2.3%. Adjusted EPS was $1.50, down 0.7% year-over-year. The company's Powering Care strategy drove volume gains and improved product mix, generating significant efficiencies.
Net sales were $4.9 billion, down 0.8 percent, with organic sales growth of 2.3 percent.
Adjusted gross margin was 35.4 percent, up 50 basis points versus the prior year.
Adjusted operating profit was $684 million, up 2.1 percent versus the prior year.
Adjusted earnings per share were $1.50, down 0.7 percent versus prior year.
Kimberly-Clark expects 2025 Organic Sales Growth to outpace the weighted average growth in the categories and countries it competes, which are currently growing at approximately two percent.
Analyze how earnings announcements historically affect stock price performance